This cooperation aims to expedite access to advanced medicines and vaccines developed by GSK, particularly by bringing to ...

Q3 2025 Earnings Call Transcript October 29, 2025 GSK plc beats earnings expectations. Reported EPS is $1.48, expectations ...

(Alliance News) - Shell launches new USD3.5 billion buyback, WPP cuts its outlook while Permanent TSB puts itself up for sale. Here is what you need to know before the London market open: FTSE 100: ...

The dollar strengthened Wednesday while Wall Street stocks were mixed after the Federal Reserve indicated its latest interest rate cut might not be repeated in December.

The blue-chip index FTSE 100 rose 0.7% and the British GBP/USD fell 0.3% against the dollar, trading above the 1.32 level. The DAX index in Germany declined 0.6%, and the CAC 40 in France fell 0.2%.

GSK's Q3 earnings and revenue beat expectations, powered by HIV and oncology growth, prompting the company to lift its 2025 outlook.

European shares reversed early gains to close mostly lower on Wednesday as investors awaited the US Federal Reserve’s latest ...

GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer medicines posted double-digit ...

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, ...

At 04:05 ET (08:05 GMT), the DAX index in Germany slipped 0.1% and the CAC 40 in France dropped 0.2%, while the FTSE 100 in ...

GSK acquires exclusive rights from Syndivia for an ADC targeting advanced prostate cancer in a deal up to £268 m, reinforcing ...